Codexis Stock Price

0.28 (1.11%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Codexis Inc CDXS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.28 1.11% 25.50 11:32:35
Open Price Low Price High Price Close Price Prev Close
25.38 24.50 25.655 25.22
Bid Price Ask Price Spread News
25.44 25.56 0.12 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,318 163,559 $ 25.38 $ 4,151,804 - 11.48 - 29.56
Last Trade Time Type Quantity Stock Price Currency
11:36:48 1 $ 25.4936 USD


Draw Mode:

Codexis Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.65B 64.64M 62.99M $ 69.06M $ -19.31M -0.40 -67.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -120.58k 4.70%

more financials information »

Codexis News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CDXS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week24.9025.7424.1425.08361,3520.602.41%
1 Month24.6728.78524.1426.18308,4720.833.36%
3 Months23.8728.78518.8723.53321,8211.636.83%
6 Months21.6928.78517.0322.23422,5923.8117.57%
1 Year11.6829.5611.4821.41496,74413.82118.32%
3 Years18.0029.568.4317.99409,2537.5041.67%
5 Years4.0329.563.6015.79336,84821.47532.75%

Codexis Description

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes and Novel Biotherapeutics. It generates maximum revenue from the Performance Enzymes segment.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.